US Stock MarketDetailed Quotes
ENZN ENZON PHARMACEUTICALS INC
- 0.150000
- 0.0000000.00%
15min DelayClose Jul 26 16:00 ET
11.13MMarket Cap50.00P/E (TTM)
0.150000High0.150000Low5.30KVolume0.150000Open0.150000Pre Close795.15Turnover0.02%Turnover Ratio150.00P/E (Static)74.21MShares0.24000052wk High3.19P/B4.52MFloat Cap0.06000052wk Low--Dividend TTM30.11MShs Float0.760000Historical High--Div YieldTTM0.00%Amplitude0.060000Historical Low0.150000Avg Price1Lot Size
ENZON PHARMACEUTICALS INC Key Stats
Quarterly+Annual
YOY
| (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | -96.29%26K | -10.34%26K | 0 | 0 |
| Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 | -96.29%26K | -10.34%26K | --0 | --0 |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | 14.39%326K | -1.32%1.04M | -8.86%216K | 1.81%225K | 4.95%318K | -4.04%285K | -9.57%1.06M | -8.85%237K | -3.07%221K | -2.88%303K |
| Selling and administrative expenses | 14.39%326K | -1.32%1.04M | -8.86%216K | 1.81%225K | 4.95%318K | -4.04%285K | -9.57%1.06M | -8.85%237K | -3.07%221K | -2.88%303K |
| -General and administrative expense | 14.39%326K | -1.32%1.04M | -8.86%216K | 1.81%225K | 4.95%318K | -4.04%285K | -9.57%1.06M | -8.85%237K | -3.07%221K | -2.88%303K |
| Operating profit | -14.39%-326K | -1.16%-1.04M | -2.37%-216K | -1.81%-225K | -4.95%-318K | 4.04%-285K | -120.04%-1.03M | 8.66%-211K | 3.07%-221K | -1,342.86%-303K |
| Net non-operating interest income expense | 44.74%647K | 250.00%2.26M | 84.68%639K | 199.04%622K | 514.44%553K | 22,250.00%447K | 646K | 346K | 208K | 90K |
| Non-operating interest income | 44.74%647K | 250.00%2.26M | 84.68%639K | 199.04%622K | 514.44%553K | 22,250.00%447K | --646K | --346K | --208K | --90K |
| Other net income (expense) | ||||||||||
| Income before tax | 98.15%321K | 415.28%1.22M | 213.33%423K | 3,153.85%397K | 210.33%235K | 154.92%162K | 16.45%-386K | 158.70%135K | 94.25%-13K | -1,021.05%-213K |
| Income tax | 102.86%1K | 22.00%-156K | -25.76%-249K | 3,700.00%76K | 52K | -775.00%-35K | -2,957.14%-200K | -4,060.00%-198K | 2K | 0 |
| Net income | 62.44%320K | 838.17%1.37M | 101.80%672K | 2,240.00%321K | 185.92%183K | 167.70%197K | 60.34%-186K | 241.70%333K | 93.36%-15K | -1,021.05%-213K |
| Net income continuous Operations | 62.44%320K | 838.17%1.37M | 101.80%672K | 2,240.00%321K | 185.92%183K | 167.70%197K | 60.34%-186K | 241.70%333K | 93.36%-15K | -1,021.05%-213K |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | 62.44%320K | 838.17%1.37M | 101.80%672K | 2,240.00%321K | 185.92%183K | 167.70%197K | 60.34%-186K | 241.70%333K | 93.36%-15K | -1,021.05%-213K |
| Preferred stock dividends | 0.00%531K | 0.00%1.28M | 0.00%-318K | 0.00%531K | 0.00%531K | 0.00%531K | -36.97%1.28M | -162.97%-318K | 4.94%531K | 4.94%531K |
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | 36.83%-211K | 106.71%98K | 52.07%990K | 61.54%-210K | 53.23%-348K | 59.37%-334K | 41.37%-1.46M | 187.97%651K | 25.41%-546K | -41.71%-744K |
| Basic earnings per share | 36.82%-0.0028 | 106.60%0.0013 | 13.20%0.0113 | 71.70%-0.0028 | 53.11%-0.0047 | 55.00%-0.0045 | 33.33%-0.02 | 200.00%0.01 | 0.00%-0.01 | 0.00%-0.01 |
| Diluted earnings per share | 36.82%-0.0028 | 106.60%0.0013 | 13.20%0.0113 | 71.70%-0.0028 | 53.11%-0.0047 | 59.37%-0.0045 | 33.33%-0.02 | 200.00%0.01 | 0.00%-0.01 | 0.00%-0.01 |
| Dividend per share | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg